Steatotic liver disease in people with human immunodeficiency virus: A narrative review of metabolic steatotic liver disorders

doi:10.4254/wjh.v18.i5.117567

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 5

This Article

(23)

(27)

(0)

(493)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Hepatol. May 27, 2026; 18(5): 117567
Published online May 27, 2026. doi: 10.4254/wjh.v18.i5.117567

Full Size Figure Download Figure

Figure 2 Summary of the main differences in antiretroviral therapy selection, monitoring, and treatment modifications in patients with and without metabolic dysfunction-associated steatotic liver disease. TAF: Tenofovir alafenamide fumarate; FTC: Emtricitabine; NNRTIs: Non-nucleoside reverse transcriptase inhibitor; MASLD: Metabolic dysfunction-associated steatotic liver disease; GLP-1RA: Glucagon-like peptide-1 receptor agonists; SGLT2i: Sodium-glucose cotransporter 2 inhibitors; ART: Antiretroviral therapy; HIV: Human immunodeficiency virus.

Citation: Garrido NJ, Suárez M, Mateo J. Steatotic liver disease in people with human immunodeficiency virus: A narrative review of metabolic steatotic liver disorders. World J Hepatol 2026; 18(5): 117567
URL: https://www.wjgnet.com/1948-5182/full/v18/i5/117567.htm
DOI: https://dx.doi.org/10.4254/wjh.v18.i5.117567

Garrido NJ, Suárez M, Mateo J. Steatotic liver disease in people with human immunodeficiency virus: A narrative review of metabolic steatotic liver disorders. World J Hepatol 2026; 18(5): 117567 [DOI: 10.4254/wjh.v18.i5.117567]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.